Literature DB >> 23849968

Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.

Shohei Ogata1, Adriana H Tremoulet, Yuichiro Sato, Kayla Ueda, Chisato Shimizu, Xiaoying Sun, Sonia Jain, Laura Silverstein, Annette L Baker, Noboru Tanaka, Yoshihito Ogihara, Satoshi Ikehara, Shinichi Takatsuki, Naoko Sakamoto, Tohru Kobayashi, Shigeto Fuse, Tomoyo Matsubara, Masahiro Ishii, Tsutomu Saji, Jane W Newburger, Jane C Burns.   

Abstract

OBJECTIVE: It has been claimed that the aneurysm rate for Kawasaki disease (KD) patients in Japan is lower than in the U.S. However it has been difficult to compare coronary artery (CA) outcomes between the two countries because of different definitions for CA abnormalities. Therefore, we compared CA internal diameters between Japanese and U.S. KD patients using standard definitions and methods. STUDY
DESIGN: We retrospectively reviewed CA outcomes in 1082 KD patients from 2 centers in the U.S. and 3 centers in Japan and compared Z-max scores (maximum internal diameter for the left anterior descending or right coronary artery expressed as standard deviation units from the mean (Z-score) normalized for body surface area) obtained within 12 weeks after onset and calculated using two different regression equations from Canada (Dallaire) and Japan (Fuse). We defined a Z-max of < 2.5 as normal and a Z-max of ≥ 10 as giant aneurysm. RESULT: The median Z-max for the U.S. and Japanese subjects was 1.9 and 2.3 SD units, respectively (p < 0.001). There was no significant difference in rates of patients with Z-max ≥ 5.0 between the countries. In a multivariable model adjusting for age, sex, and treatment response, being Japanese was still associated with a higher Z-max score.
CONCLUSION: Previously reported differences in aneurysm rates between Japan and the U.S. likely resulted from use of different definitions and nomenclature. Adoption of Z-scores as a standard for reporting CA internal diameters will allow meaningful comparisons among different countries and will facilitate international, collaborative clinical trials.
© 2013. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery aneurysm; Echocardiography; Kawasaki disease; Vasculitis; Z score

Mesh:

Year:  2013        PMID: 23849968      PMCID: PMC4002741          DOI: 10.1016/j.ijcard.2013.06.027

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  34 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

2.  Nationwide survey of Kawasaki disease and acute rheumatic fever.

Authors:  K A Taubert; A H Rowley; S T Shulman
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

3.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Coronary diameter in normal infants, children and patients with Kawasaki disease.

Authors:  Shunji Kurotobi; Toshisaburo Nagai; Nobuhiro Kawakami; Tetsuya Sano
Journal:  Pediatr Int       Date:  2002-02       Impact factor: 1.524

5.  Predictors of body surface area.

Authors:  Y Wang; J Moss; R Thisted
Journal:  J Clin Anesth       Date:  1992 Jan-Feb       Impact factor: 9.452

6.  Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults.

Authors:  G B Haycock; G J Schwartz; D H Wisotsky
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

7.  Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases.

Authors:  A Suzuki; T Kamiya; N Kuwahara; Y Ono; T Kohata; O Takahashi; K Kimura; M Takamiya
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

8.  Smoothing reference centile curves: the LMS method and penalized likelihood.

Authors:  T J Cole; P J Green
Journal:  Stat Med       Date:  1992-07       Impact factor: 2.373

Review 9.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

10.  Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Satoshi Tsuboi; Yasuko Aoyama; Kazuhiko Kotani; Enkh-Oyun Tsogzolbaatar; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2012-03-10       Impact factor: 3.211

View more
  31 in total

1.  Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years.

Authors:  Hua Zhu; Shao-Fei Yu; Yu-Xin Bai; Yan-Yan Liang; Xue-Wen Su; Jing-Ying Pan
Journal:  Exp Ther Med       Date:  2015-05-11       Impact factor: 2.447

Review 2.  2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.

Authors:  Frank Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2021-02-06       Impact factor: 3.725

3. 

Authors:  Teeranai Sakulchit; Susanne M Benseler; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

Review 4.  Acetylsalicylic acid for children with Kawasaki disease.

Authors:  Teeranai Sakulchit; Susanne M Benseler; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

5.  Response to "Acute kidney injury occurs only rarely in patients with Kawasaki disease".

Authors:  Gwo-Tsann Chuang; Luan-Yin Chang
Journal:  Pediatr Res       Date:  2017-09-20       Impact factor: 3.756

Review 6.  Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Authors:  Jane C Burns; Isabelle Koné-Paut; Taco Kuijpers; Chisato Shimizu; Adriana Tremoulet; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

7.  Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.

Authors:  Masaru Miura; Tohru Kobayashi; Tetsuji Kaneko; Mamoru Ayusawa; Ryuji Fukazawa; Naoya Fukushima; Shigeto Fuse; Kenji Hamaoka; Keiichi Hirono; Taichi Kato; Yoshihide Mitani; Seiichi Sato; Shinya Shimoyama; Junko Shiono; Kenji Suda; Hiroshi Suzuki; Jun Maeda; Kenji Waki; Hitoshi Kato; Tsutomu Saji; Hiroyuki Yamagishi; Aya Ozeki; Masako Tomotsune; Makiko Yoshida; Yohei Akazawa; Kentaro Aso; Shouzaburoh Doi; Yoshi Fukasawa; Kenji Furuno; Yasunobu Hayabuchi; Miyuki Hayashi; Takafumi Honda; Norihisa Horita; Kazuyuki Ikeda; Masahiro Ishii; Satoru Iwashima; Masahiro Kamada; Masahide Kaneko; Hiroshi Katyama; Yoichi Kawamura; Atushi Kitagawa; Akiko Komori; Kenji Kuraishi; Hiroshi Masuda; Shinichi Matsuda; Satoshi Matsuzaki; Sayaka Mii; Tomoyuki Miyamoto; Yuji Moritou; Noriko Motoki; Kiyoshi Nagumo; Tsuneyuki Nakamura; Eiki Nishihara; Yuichi Nomura; Shohei Ogata; Hiroyuki Ohashi; Kenichi Okumura; Daisuke Omori; Tetsuya Sano; Eisuke Suganuma; Tsutomu Takahashi; Shinichi Takatsuki; Atsuhito Takeda; Masaru Terai; Manatomo Toyono; Kenichi Watanabe; Makoto Watanabe; Masaki Yamamoto; Kenichiro Yamamura
Journal:  JAMA Pediatr       Date:  2018-05-07       Impact factor: 16.193

Review 8.  Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Authors:  Victoria C Ziesenitz; Tatjana Welzel; Madelé van Dyk; Patrick Saur; Matthias Gorenflo; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2022-09-02       Impact factor: 3.930

9.  Coronary Diameters in Taiwanese Children Younger than 6 Years Old: Z-Score Regression Equations Derived from Body Surface Area.

Authors:  Ming-Tai Lin; Chin-Hao Chang; Wen-Chin Hsieh; Chi-En Chang; Ya-Mei Chang; Yung-Chuan Chen; Jui-Yu Hsu; Yi-Ling Huang; Juine-Yih Ma; Li-Chuan Sun; Chi-Sen Wu; Su-Zen Yeh; Wei-Quan Fang; Chun-An Chen; Shuenn-Nan Chiu; Chun-Wei Lu; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2014-07       Impact factor: 2.672

10.  Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.

Authors:  Neil E Bowles; Cammon B Arrington; Keiichi Hirono; Tsuneyuki Nakamura; Long Ngo; Yin Shen Wee; Fukiko Ichida; John H Weis
Journal:  Mol Genet Genomic Med       Date:  2014-05-14       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.